Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of Diacerein and Celecoxib in Patients With Knee Osteoarthritis
NCT03404479Phase 4Unknown
- Start
- Jan 2018
- Primary completion
- Jan 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of diacerein and celecoxib oral solution in knee osteoarthritis (OA) (3 arms). Primary endpoint: Pain Visual Analog Scale at 12 weeks. Status: unknown.
02
Drugs
diacereincelecoxib oral solution
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03404479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404479.